Trials / Completed
CompletedNCT03367247
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
Detailed description
Hospitalizations can be difficult for patients with cancer, especially when they are transitioning home. Patients and caregivers are often expected to perform complex medical and nursing tasks with little or no preparation. Patients and caregivers report high levels of unmet needs for information about how best to manage symptoms and new medical procedures (such as managing new tubes, lines or drains). The study team has developed a research project which aims to address these needs. If a patient agrees to participate in the study, she will take part in a program called BOLSTER (Building Out Lifelines for Safety, Trust, Empowerment and Renewal). BOLSTER will provide patients and caregivers with education and skills training, symptom management, and support across care settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | BOLSTER | BOLSTER provides patients and caregivers with education and skills training, symptom management, and support across care settings over a four-week period. |
| OTHER | Enhanced Discharge Planning (EDP) | EDP provides patients and caregivers a single session of education and skills training, symptom management, and support. |
Timeline
- Start date
- 2018-04-24
- Primary completion
- 2022-06-30
- Completion
- 2023-07-27
- First posted
- 2017-12-08
- Last updated
- 2026-03-10
- Results posted
- 2023-08-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03367247. Inclusion in this directory is not an endorsement.